1. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice;P DeMatos,1998
2. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer;AE Chang,2002
3. Tumor lysate pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery;W Asavaroengchai,2002
4. Phase I trial of intravenous peptide pulsed dendritic cells in patients with metastatic melanoma;R Lau,2001
5. Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phaseI/II clinical trial;G Pecher,2002